Differentiation of division I (cfiA-negative) and division II (cfiA-positive) Bacteroides fragilis strains by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

Differentiation of cfiA-Negative and cfiA-Positive Bacteroides fragilis Isolates by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry

(2011) I. Wybo et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, a revolution in clinical microbial identification

(2010) A. Bizzini et al.   CLINICAL MICROBIOLOGY AND INFECTION

Detection of microorganisms in blood specimens using matrix-assisted laser desorption ionization time-of-flight mass spectrometry: a review

(2010) M. Drancourt   CLINICAL MICROBIOLOGY AND INFECTION

Matrix-assisted laser desorption ionization time-of-flight mass spectrometry: usefulness for taxonomy and epidemiology

(2010) P.R. Murray   CLINICAL MICROBIOLOGY AND INFECTION

Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience

(2010) E. Nagy et al.   CLINICAL MICROBIOLOGY AND INFECTION

Anaerobic Infections

(2010) Elisabeth Nagy   DRUGS

Species identification of clinical isolates of Bacteroides by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry

(2009) E. Nagy et al.   CLINICAL MICROBIOLOGY AND INFECTION

MALDI-TOF MS-based drug susceptibility testing of pathogens: The example ofCandida albicansand fluconazole

(2009) Carine Marinach et al.   PROTEOMICS